Corsearch

FEBRUARY 16, 2024

AstraZeneca’s brand protection journey is one of close collaboration, ‘learning by doing’, and adaptation in the face of new threats. Table of contents : • The start of AstraZeneca’s brand protection journey • Illegally diverted medicines, scams, and counterfeits – where does AstraZeneca focus its efforts? •

Branding 52

Branding Brands Branding Marketing 52

IP and Legal Filings

NOVEMBER 6, 2022

It supports the numerous stakeholders who are engaged behind and in front of the scenes, it enables producers to get the funding required to launch production or marketing campaigns, and encourages technology advancements that push the bounds of creativity and make them possible.[1]. Image Source:iStock]. Intellectual Property Ownership.

Ownership 52

Ownership Intellectual Property IP Contracts 52

IIPRD

NOVEMBER 14, 2023

of the population of India having ingress to the world wide web and ever growing e-commerce market which is forecasted to reach about twenty billion euros by 2030, it becomes pertinent to analyse the interconnect between these two. [1] Signing confidentiality agreements also are one of the ways of protection. [8]

Intellectual Property 59

Intellectual Property Due Diligence Journalism IP 59

SpicyIP

NOVEMBER 8, 2023

Speaking of this topic, I can’t miss Bedaquiline , the first new drug to receive approval to treat tuberculosis (TB) in over 40 years, which raised serious questions about its marketing approval without mandatory Phase III clinical trials in India and around informed consent of Indian patients. However, 2023 seems good for Google, thus far.

Trademark 59

Trademark Publishing Journalism Copyright 59

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. In addition, fewer new biosimilars entered the market this past year, with five biosimilar launches in 2020 as compared to seven in 2019. Yet biosimilars of anti-TNF?

Settlement 52

Settlement Litigation Marketing Marketing 52

IIPRD

MAY 4, 2023

The portion of the total market that involves electronically enabled medical devices continues to expand. A case in point is patent application 634/MUMNP/2010 , where the claims recited a method for monitoring the pressure of an inflatable cuff of an airway device, and did not mention any use of the device on the human body.

Intellectual Property 52

Intellectual Property Invention Public Domain Patent 52

SpicyIP

DECEMBER 30, 2023

Eventually, Johnson and Johnson announced that it would no longer enforce their patents for Bedaquiline (brand name: Sirturo) which is used in the treatment of multidrug-resistant tuberculosis (MDR-TB) in 134 low- and middle-income countries. Meticulous Market Research Pvt. The rejection order is authored by Dr. Latika Dawara, Asst.

IP 124

IP Copyright Trademark Intellectual Property 124